Engineers Gate Manager LP Vyne Therapeutics Inc. Transaction History

Engineers Gate Manager LP

  • $4.86 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$0.5 - $1.15 $16,655 - $38,307
-33,311 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$0.91 - $1.5 $30,313 - $49,966
33,311 New
33,311 $34,000
Q3 2021

Nov 15, 2021
SELL
$1.39 - $3.47 $21,857 - $54,565
-15,725 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$3.24 - $6.92 $28,586 - $61,055
-8,823 Reduced 35.94%
15,725 $55,000
Q1 2021

May 17, 2021
BUY
$6.34 - $12.68 $155,634 - $311,268
24,548 New
24,548 $168,000

Others Institutions Holding VYNE

# of Institutions
2
Shares Held
36.5K
Call Options Held
0
Put Options Held
0
View Full List

About VYNE Therapeutics Inc.

VYNE Quotes by TradingView
  • Ticker VYNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,005,600
  • Market Cap $179M
  • Description
  • VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, whi...
More about VYNE
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email